Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the MiR‑124‑3p/EZH2 Signaling Pathway

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2021 Jan 8

PMID 33416105

Citations 27

Authors

Xiaoyun Yang

Jianjun Wang

Huaifang Li

Yi Sun

Xiaowen Tong

Affiliations

Soon will be listed here.

Abstract

Circular RNAs (circRNAs) play a role in various types of cancer. The present study suggested that hsa_circ_0026123 expression was upregulated in ovarian cancer (OVA), which was associated with its role in OVA. However, the role of hsa_circ_0026123 in OVA cell invasion and proliferation remains unclear. In the present study, OVA tissues and cell lines were used to investigate the functions of hsa_circ_0026123. The associations between hsa_circ_0026123, miR‑124‑3p and enhancer of zeste homolog 2 (EZH2) were examined using a luciferase reporter assay. RT‑qPCR and western blot analysis were used for gene and protein expression analysis, respectively. Tumor growth was detected using nude mouse tumor xenografts derived from SKOV3 cells, with or without hsa_circ_0026123 downregulation. The results confirmed that hsa_circ_0026123 expression was upregulated in OVA tissues and cell lines, while hsa_circ_0026123 silencing suppressed cell proliferation and migration; it also suppressed the expression of cancer stem cell (CSC) differentiation‑related markers in either in vivo or in vitro experiments. The data revealed that hsa_circ_0026123 downregulation suppressed EZH2 expression by miR‑124‑3p 'sponging', which was confirmed by rescue experiments and luciferase reporter assays. The results revealed that hsa_circ_0026123 silencing suppressed ovarian cancer cell progression via the miR‑124‑3p/EZH2 signaling pathway. Overall, the findings demonstrated that hsa_circ_0026123 knockdown inhibited OVA cell progression by regulating the miR‑124‑3p/EZH2 axis. This methodology may thus be used for the targeted therapy of OVA, as well as a candidate biomarker for the diagnosis and treatment of OVA.

Citing Articles

Treating human cancer by targeting EZH2.

Xu M, Xu C, Wang R, Tang Q, Zhou Q, Wu W Genes Dis. 2025; 12(3):101313.

PMID: 40028035 PMC: 11870178. DOI: 10.1016/j.gendis.2024.101313.

Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.

Schwarzenbach H Noncoding RNA. 2024; 10(5).

PMID: 39452837 PMC: 11510331. DOI: 10.3390/ncrna10050051.

The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential.

Malek Mohammadi M, Rismanchi H, Esmailzadeh S, Farahani A, Hedayati N, Alimohammadi M Noncoding RNA Res. 2024; 9(4):1280-1291.

PMID: 39040815 PMC: 11261309. DOI: 10.1016/j.ncrna.2024.05.005.

circ-TFRC downregulation suppresses ovarian cancer progression via miR-615-3p/IGF2 axis regulation.

Yan Z, Duan C, Li X, Wang H, Li S, Zhou X Cancer Cell Int. 2024; 24(1):152.

PMID: 38678242 PMC: 11056059. DOI: 10.1186/s12935-024-03287-4.

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Weidle U, Birzele F Cancer Genomics Proteomics. 2024; 21(3):213-237.

PMID: 38670587 PMC: 11059596. DOI: 10.21873/cgp.20442.

References

Cui R, Fan J, Lin Y, Pan Y, Liu C, Wan J . miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma. Cancer Med. 2019; 8(14):6358-6369. PMC: 6797582. DOI: 10.1002/cam4.2482. View

Zhang S, Chen X, Li C, Li X, Liu C, Liu B . Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy. Invest Ophthalmol Vis Sci. 2017; 58(14):6500-6509. DOI: 10.1167/iovs.17-22698. View

Liu G, Shi H, Deng L, Zheng H, Kong W, Wen X . Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer. Biochem Biophys Res Commun. 2019; 513(1):207-212. DOI: 10.1016/j.bbrc.2019.03.213. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Chen J, Luo X, Xiang L, Li H, Zha L, Li N . EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling. Oncotarget. 2016; 7(27):41540-41558. PMC: 5173077. DOI: 10.18632/oncotarget.9236. View

Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J . CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer. Mol Cancer. 2019; 18(1):144. PMC: 6796346. DOI: 10.1186/s12943-019-1080-5. View

Shan K, Liu C, Liu B, Chen X, Dong R, Liu X . Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus. Circulation. 2017; 136(17):1629-1642. DOI: 10.1161/CIRCULATIONAHA.117.029004. View

Li J, Yang J, Zhou P, Le Y, Zhou C, Wang S . Circular RNAs in cancer: novel insights into origins, properties, functions and implications. Am J Cancer Res. 2015; 5(2):472-80. PMC: 4396047. View

Guan Y, Ma J, Song W . Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data. Cancer Cell Int. 2019; 19:183. PMC: 6636116. DOI: 10.1186/s12935-019-0905-z. View

10.

Nishimoto S, Hamajima Y, Toda Y, Toyoda H, Kitamura K, Komurasaki T . Identification of a novel smooth muscle associated protein, smap2, upregulated during neointima formation in a rat carotid endarterectomy model. Biochim Biophys Acta. 2002; 1576(1-2):225-30. DOI: 10.1016/s0167-4781(02)00345-7. View

11.

Piwecka M, Glazar P, Hernandez-Miranda L, Memczak S, Wolf S, Rybak-Wolf A . Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017; 357(6357). DOI: 10.1126/science.aam8526. View

12.

Liu J, Song S, Lin S, Zhang M, Du Y, Zhang D . Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ. Cell Prolif. 2019; 52(4):e12648. PMC: 6668981. DOI: 10.1111/cpr.12648. View

13.

Doubeni C, Doubeni A, Myers A . Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016; 93(11):937-44. View

14.

Sheng M, Wei N, Yang H, Yan M, Zhao Q, Jing L . CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144. Eur Rev Med Pharmacol Sci. 2019; 23(17):7283-7294. DOI: 10.26355/eurrev_201909_18833. View

15.

Zhao M, Hu X, Xu Y, Wu C, Chen J, Ren Y . Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Int J Oncol. 2019; 55(5):1165-1175. DOI: 10.3892/ijo.2019.4880. View

16.

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J . Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015; 25(8):981-4. PMC: 4528056. DOI: 10.1038/cr.2015.82. View

17.

Maier S, Paulsson M, Hartmann U . The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration. Exp Cell Res. 2008; 314(13):2477-87. DOI: 10.1016/j.yexcr.2008.05.020. View

18.

Gao Y, Zhang C, Liu Y, Wang M . Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer. Biosci Trends. 2019; 13(2):204-211. DOI: 10.5582/bst.2019.01021. View

19.

Wilusz J, Sharp P . Molecular biology. A circuitous route to noncoding RNA. Science. 2013; 340(6131):440-1. PMC: 4063205. DOI: 10.1126/science.1238522. View

20.

Lv Y, Chen S, Wu J, Lin R, Zhou L, Chen G . Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway. Artif Cells Nanomed Biotechnol. 2019; 47(1):2083-2090. DOI: 10.1080/21691401.2019.1617727. View